Genmab (GMAB) - P/S ratio

P/S ratio as of October 2026 (TTM): 5.37

According to Genmab's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.72. At the end of 2026 the company had a P/S ratio of 3.88.

P/S ratio history for Genmab from 2023 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2026	3.88	-86.32%
2025	28.4	-12.51%
2024	32.4	-41.88%
2023	55.8	-39.07%
2022	91.6	-28.98%
2021	129	21.9%
2020	106	-9.73%
2019	117	-13.71%
2018	136	-21%
2017	172	-35.61%
2016	267	-18.65%
2015	328	146.34%
2014	133	41.55%
2013	94.1	104.95%
2012	45.9	81.97%
2011	25.2	-25.69%
2010	34.0

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Genmab (GMAB)